CMPI Stock Forecast & Price Target
CMPI Stock
Price Forecast
The average stock forecast for
Checkmate Pharmaceuticals Inc (CMPI) in the next 12 months is 12.75 USD. This price target corresponds to an upside
of
21.43%. The range of stock forecasts for CMPI is 6.06 - 19.95 USD.
Based on the ratings of 8 analysts, the consensus recommendation for CMPI is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
6.06 |
12.75 |
12.75 |
19.95 |
| Upside |
-42.29% |
21.43% |
21.43% |
90.00% |
Recommendation Trends
The latest consensus rating for CMPI is "BUY". This is the average
recommendation of 8 analysts: 0 strong sell,
0 sell, 2 hold, 3 buy, 3 strong buy. In the previous period, 9 analysts also majorly recommmended
"STRONGBUY" for CMPI.
CMPI Financial Stock
Forecast
Revenue This Year
from -M
Revenue Next Year
from -M